Annette M. Tobia

Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA.

BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom.

Arcturus Pharmaceutical Corp. is a private company that manufactures and supplies pharmaceutical products. The company is based in Malvern, PA.

The Fox Chase Cancer Center owns and operates hospitals. It is an independent, non-profit institution that is engaged in cancer treatment, research and prevention services. The firm's staff provides consultations and treatment recommendations for different types of adult cancer. The company was founded in 1904 and is headquartered in Philadelphia, PA.

QED Technologies International, Inc. develops polishing and metrology technology for semiconductors. The company is based in Rochester, NY. The company was founded in 1996 by Lowell A. Mintz, Donald Golini. The CEO is Bertrand Loy. QED Technologies International was acquired by CMC Materials LLC, part of Entegris, Inc. from July 07, 2022 on July 10, 2006 for $23.50 million.

Dynamis Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. It develops drugs diabetic complications and other autoimmune diseases. The company is headquartered in Jenkintown, PA.